Dennis Jensen
David Geffen School of Medicine Medicine at UCLA
Appearances
- DateMay 6, 2023SOCIETY: ASGE
Moderators
David Geffen School of Medicine Medicine at UCLALouis Stokes VA Medical Center - DateMay 6, 2023SOCIETY: ASGE
Presenter
David Geffen School of Medicine Medicine at UCLA - DateMay 6, 2023SOCIETY: ASGE
Presenter
David Geffen School of Medicine Medicine at UCLA - DateMay 9, 2023BACKGROUND: Biological treatment in inflammatory bowel disease (IBD) patients is currently hampered by high non-response rates. To enhance personalized medicine and predict response to biological therapeutics such as vedolizumab, the working mechanism should be elucidated…
Presenter
David Geffen School of Medicine Medicine at UCLA - DateMay 9, 2023BACKGROUND: Biological treatment in inflammatory bowel disease (IBD) patients is currently hampered by high non-response rates. To enhance personalized medicine and predict response to biological therapeutics such as vedolizumab, the working mechanism should be elucidated…
Speakers
Presenter
- DateMay 19, 2024
Presenter
David Geffen School of Medicine Medicine at UCLA - DateMay 20, 2024
Presenter
David Geffen School of Medicine Medicine at UCLA - DateMay 20, 2024The current GI guideline recommendations for early diagnosis and lesion localization of patients with severe LGIB are to perform computerized tomography angiography (CTA) or labelled red blood cell (RBC) scanning and not urgent colonoscopy. However, only active bleeding (e.g…
Presenter
David Geffen School of Medicine Medicine at UCLA - DateMay 20, 2024INTRODUCTION: Hemoclip (HC) closure has mixed success rates for prevention of delayed post-polypectomy induced ulcer hemorrhage (DPPIUH). This is because HC is a single layer closure which buries submucosal arteries, often without obliterating blood flow…
Presenter
David Geffen School of Medicine Medicine at UCLA